Zensar Technologies: Q4FY25 Result Review
IDBI Capital
Broker Research reports: latest Upgrades
for all stocks
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 Apr 2025 | Zensar Technologies |
IDBI Capital
|
785.00 | 810.00 | 721.05 (8.87%) | Target met |
Buy
|
||||
| 28 Apr 2025 | Cholamandalam |
IDBI Capital
|
1635.00 | 1630.00 | 1525.80 (7.16%) | Target met |
Hold
|
||||
| 28 Apr 2025 | IDFC First Bank |
Axis Direct
|
68.79 | 68.00 | 66.50 (3.44%) | Target met |
Hold
|
||||
| 28 Apr 2025 | DCB Bank |
Axis Direct
|
143.00 | 160.00 | 139.45 (2.55%) | 11.89 |
Buy
|
||||
| 28 Apr 2025 | Shriram Finance |
Axis Direct
|
677.80 | 790.00 | 622.00 (8.97%) | 16.55 |
Buy
|
||||
| 28 Apr 2025 | Tata Consumer |
KRChoksey
|
1150.00 | 1278.00 | 1155.70 (-0.49%) | 11.13 |
Accumulate
|
Resilient performance amid cost headwinds; gradual recovery on the horizon
KRChoksey
TCPL’s Q4FY25 consolidated revenue stood at INR 46,082 Mn up 17.3% YoY (+3.7% QoQ), which was above our estimates by 1.7%.
EBITDA came it at INR 6,210 Mn down1.4% YoY (+10.0% QoQ), which was below our estimates by 4.5% driven by higher-than-expected operating expenses. |
|||
| 28 Apr 2025 | Persistent Systems |
KRChoksey
|
5669.00 | 5324.00 | 5273.50 (7.50%) | Target met |
Hold
|
Retains USD 2 Bn target by FY27E, despite macro economic headwinds
KRChoksey
PSYS revenue for Q4FY25 came in at INR 32,421 Mn, up 25.2% YoY (+5.9% QoQ), in line with our estimates (+1.2%). EBIT grew to INR 5,053 Mn, up 34.9% YoY (+10.9% QoQ), beating our estimates, due to lower-than-anticipated employee expense, partially offset by higher other expenses.
|
|||
| 27 Apr 2025 | DCB Bank |
BOB Capital Markets Ltd.
|
143.00 | 160.00 | 127.03 (12.57%) | 11.89 |
Buy
|
||||
| 27 Apr 2025 | Macrotech Developers |
ICICI Securities Limited
|
1421.00 | 1284.00 | 1305.10 (8.88%) | Target met |
Hold
|
||||
| 27 Apr 2025 | Orient Electric |
Anand Rathi
|
232.60 | 310.00 | 241.38 (-3.64%) | 33.28 |
Buy
|
Lighting outshines, double-digit margins targeted; maintaining a Buy
Anand Rathi
Weak prolonged winter season impacted Orient Electric’s water heater and fan sales, while lighting outperformed led by strong B2B demand. Fan demand recovered over the past 7–8 days, and management remains optimistic about Q1 performance, supported by severe summer forecast across India.
|
|||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.